investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Randomized trial of 2 versus 3 doses of HPV vaccine in India

Rengaswamy Sankaranarayanan

0 Collaborator(s)

Funding source

Bill & Melinda Gates Foundation

No posts

Related projects

Ronald T Mitsuyasu

AIDS Malignancy Clinical Trials Consortium (AMC)

Cervix uteri

Michael Frumovitz

A Phase III Randomized Study of Pretherapeutic Para-aortic Lymphadenectomy in Women With Locally Advanced Cervical Cancer Dispositioned to Definitive Chemoradiotherapy

Cervix uteri

Radiation Oncology

Charles D Blanke

SWOG Network Group Operations Center of the NCTN

Cervix uteri

Anna R Giuliano

Preparedness Study to Test the Future Efficacy of HPV Vaccine to Reduce HIV Infection

Cervix uteri

Global Noncommunicable Diseases Intiatives

PCI. Impact, risk factor and modern diagnosis techniques for the detection of the human papillomavirus

Cervix uteri

Zhi-Ming Zheng

Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses

Cervix uteri

Mark Schiffman

Nigerian HPV Screening Project

Cervix uteri

Global Noncommunicable Diseases Intiatives

Cervical cancer prevention: Sharing best practices and critical data and expanding screening capacity

Cervix uteri

Investigator from VLP The Vaccines Company

New Generation Therapeutic vaccine for the Treatment of HPV infections and Cervical Dysplasia

Cervix uteri